(Total Views: 362)
Posted On: 07/01/2021 9:53:39 PM
Post# of 148908
All the wrong people on the only ones supporting the 6% group. The same names that have always bashed CYDY as well as new screen names drummed up a couple weeks ago. The next 6 month pathway and foundation has already been layer by Dr Kelly , Dr Recknor, and Nadar. I very much like we’re the stock and company is headed. Current SP is just temporary and not even Close to current actual value. If these 6% actually though they had a chance they wouldn’t be all over message boards like the bashers and FUD spreader have been for years. If they truly thought they had a chance and believed management is the only problem/reason leronlimab is not an approved drug they would be buying up shares in the millions each day and recruiting more to join their group and buy more shares making their votes count more. SP has gone down ever since the 13-d group was announced let that correlation sink in. They had an opportunity to load up on the cheap and didn’t. We need a better trial design that will be a level playing field unlike when we had 75% + folks that were over age 65 and could Only use 2 doses. I believe the née trIals starting soon will be very advantageous to showcase what leronlimab can do vs a placebo group of equal comparison. This whole 13-d bologna is just another distraction to try and move price either up or down, the day traders and short bashers make no money when volume is low and SP doesn’t move more than a couple pennies and I’m ok with that because as soon as we get closer and closer to 1st major catalyst the SP will rocket back up fueled by shorts having to cover and new investors.
(9)
(0)
Scroll down for more posts ▼